Investment
Features
FeesSafety
Academy
More
Pluang+

Compare SPDR Gold Trust (GLD) vs Nuwellis Inc (NUWE) Price & Performance

SPDR Gold TrustTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

SPDR Gold Trust vs Nuwellis Inc — how do they compare? SPDR Gold Trust trades at $368.15, while Nuwellis Inc trades at $2.84 (market cap $1.10M). The key difference: SPDR Gold Trust is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

GLDNUWE
52-Week High
$495.90$558.26
52-Week Low
$300.96$2.80
Market Cap
$1.10M
Sector
Technology
Enterprise Value
-$709.83K

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SPDR Gold Trust

GLD, tracking physical gold prices, trades at $365.98, down 1.66% amid a bearish technical signal with moving averages indicating selling pressure. Recent U.S. economic data, including jobless claims and inflation figures, influence gold's short-term volatility, while central bank accumulation provides underlying support. The ETF lacks traditional financial ratios as it holds bullion, with performance tied directly to gold market dynamics and macroeconomic factors.

The outlook for GLD hinges on gold's response to Federal Reserve policy and geopolitical tensions, offering a hedge against inflation but facing headwinds from a stronger dollar and rising yields. Risks include interest rate sensitivity and market sentiment shifts, with investors monitoring key resistance near $375 for breakout potential.

Nuwellis Inc

Nuwellis (NUWE) trades at $3.22, up 15% in the last 24 hours, following a recent 35:1 reverse stock split executed on June 26, 2026. The medical technology company shows a mixed financial picture with a strong gross margin of 65.47% but significant net losses and negative profitability ratios. Recent news highlights expansion in pediatric care, new patent awards, and a $6 million public offering closed in June 2026 to fund operations. Technical indicators are predominantly bearish, with moving averages signaling strong selling pressure.

The outlook remains challenging due to persistent operating losses and negative cash flow, offset by strategic pediatric market expansion and new product innovation. Investment opportunity hinges on the company's ability to translate its high gross margin and recent capital raise into sustainable revenue growth and eventual profitability. Key risks include continued cash burn, execution of commercial strategy, and reliance on financing activities to fund operations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About SPDR Gold Trust

GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.

Read more on GLD

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE